Optimizing Hepatitis B Vaccine Response Through the Use of a Topical Immune Modulator

NCT00175435 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
39
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

University of British Columbia